The prognosis of breast cancer patients with high TLR3 expression is relatively poor, which may be because the activation of TLR3 triggers the β-catenin and NF-κB signaling pathways, which promotes the transformation of breast cancer cells into cancer stem cells [15]. The gene discussed is TLR3; the disease is cancer.